Literature DB >> 15950800

Computerized analysis of mesothelioma on CT scans.

Samuel G Armato1.   

Abstract

Computed tomography (CT) has become an essential tool for monitoring the progression of mesothelioma tumor or a patient's response to treatment. Despite the accepted role of CT for the evaluation of mesothelioma, however, the current standard practice remains the manual measurement of tumor extent on CT scans. The process of manual measurement acquisition is tedious and subject to inconsistency. We have quantitatively assessed the variability of manual mesothelioma measurements both in baseline CT scans and in the context of tumor response classification across temporally sequential scans. To facilitate the acquisition of mesothelioma measurements, we have developed and evaluated computerized methods for the assessment of mesothelioma tumor thickness on CT scans; we anticipate that such computer-assisted approaches will make the radiologic assessment of mesothelioma more efficient, thus facilitating the establishment of improved clinical protocols.

Entities:  

Mesh:

Year:  2005        PMID: 15950800     DOI: 10.1016/j.lungcan.2005.03.011

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  2 in total

Review 1.  Segmentation and Image Analysis of Abnormal Lungs at CT: Current Approaches, Challenges, and Future Trends.

Authors:  Awais Mansoor; Ulas Bagci; Brent Foster; Ziyue Xu; Georgios Z Papadakis; Les R Folio; Jayaram K Udupa; Daniel J Mollura
Journal:  Radiographics       Date:  2015 Jul-Aug       Impact factor: 5.333

2.  North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study.

Authors:  Ritu R Gill; David P Naidich; Alan Mitchell; Michelle Ginsberg; Jeremy Erasmus; Samuel G Armato; Christopher Straus; Sharyn Katz; Demetrois Patios; William G Richards; Valerie W Rusch
Journal:  J Thorac Oncol       Date:  2016-05-12       Impact factor: 15.609

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.